ACE2, a promising therapeutic target for pulmonary hypertension.
about
Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial HypertensionThe central renin-angiotensin system and sympathetic nerve activity in chronic heart failure.Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failureSelective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.Apelin and pulmonary hypertension.Alternative Roles of STAT3 and MAPK Signaling Pathways in the MMPs Activation and Progression of Lung Injury Induced by Cigarette Smoke Exposure in ACE2 Knockout MiceTherapeutic potential of targeting the renin angiotensin system in portal hypertension.The renin-angiotensin system in 2011: new avenues for translational research.Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system[Pyr1]Apelin-13(1-12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13.Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitroRenin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.Rhodiola: an ordinary plant or a promising future therapy for pulmonary hypertension? a brief review.Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation.Molecular and cellular mechanisms of the inhibitory effects of ACE-2/ANG1-7/Mas axis on lung injury.Future drug discovery in renin-angiotensin-aldosterone system intervention.Caffeine causes pulmonary hypertension syndrome (ascites) in broilers.Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.Angiotensin II: tapping the cell cycle machinery to kill endothelial cells.Effect of a stable Angiotensin-(1-7) analogue on progenitor cell recruitment and cardiovascular function post myocardial infarction.ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.Maternal-pup interaction disturbances induce long-lasting changes in the newborn rat pulmonary vasculature.Whole genome resequencing identifies the CPQ gene as a determinant of ascites syndrome in broilers.Propofol increases angiotensin-converting enzyme 2 expression in human pulmonary artery endothelial cells.Altered regional blood flow distribution in Mas-deficient mice.
P2860
Q28085007-DB7B88D8-0DA0-4227-8A1A-81791240C525Q33742540-36747F2E-D5D6-4DA1-985E-D3795F8C3B32Q35278101-887C5D0F-2582-4983-8B9A-58AC87F2CF74Q35484295-E0090C01-06F5-4BE6-8B1D-351A24DF2E53Q35573931-4E1134AC-E890-44DF-8497-C37CC69E5614Q36727116-8ED05DA0-C7A3-4AC5-A459-09D19C97FB69Q36769062-068E51DD-B909-48A9-A3D9-2C2D15F1C48CQ36979856-4D2DA24B-7572-4988-A325-B359B929B487Q37070077-3FC2925F-6C53-4C85-A3A0-32118120EFCEQ37371071-9FBC9049-49A9-48E4-A112-B06395D9C353Q37670483-8C0D45E9-7493-4F18-A6F6-9D151933EE13Q37731227-4B18B3A2-0314-4770-9C9F-CF039B2CD3CEQ38023517-D51F72F0-1B00-4978-89F1-47C32C1D188CQ38195160-959D60B6-E191-49AD-A63F-77FE7CF575D6Q38423843-16AD4376-AAF7-4DED-BF74-53BDBFE086DAQ38543053-3424F5C6-FBA5-4CBE-B75A-E606004D6131Q38679303-2D32F994-3104-42D7-B6A1-7F1F93AB1D95Q39803578-9063FDF8-DA60-48C1-AC8B-587260273AF4Q42124925-7FCDD753-F131-4C81-AFF1-9D116240B6A1Q42428820-44F6CC80-7088-411B-B46E-0F6B223AE045Q43169811-4B9A3B88-2E2B-45CA-98CB-0CE1D4CB3B5CQ45287587-B9C0E90D-8C5E-471E-AC2E-2B79F2E4AF01Q46674014-8102A110-5D99-4DC9-9CD3-DAF8C8041FBEQ47224126-AD783650-4F2F-43D0-B0BC-8E8C7B158103Q48120793-B369919D-26F0-478B-8B78-C7DEB0478C66Q48125284-E534537B-68A2-47DB-A764-5E13BC44F433
P2860
ACE2, a promising therapeutic target for pulmonary hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ACE2, a promising therapeutic target for pulmonary hypertension.
@en
ACE2, a promising therapeutic target for pulmonary hypertension.
@nl
type
label
ACE2, a promising therapeutic target for pulmonary hypertension.
@en
ACE2, a promising therapeutic target for pulmonary hypertension.
@nl
prefLabel
ACE2, a promising therapeutic target for pulmonary hypertension.
@en
ACE2, a promising therapeutic target for pulmonary hypertension.
@nl
P2093
P2860
P1476
ACE2, a promising therapeutic target for pulmonary hypertension.
@en
P2093
Michael J Katovich
Mohan K Raizada
Vinayak Shenoy
P2860
P304
P356
10.1016/J.COPH.2010.12.002
P577
2011-01-05T00:00:00Z